Polyhemoglobin-Catalase-SuperoxideDismutase-CarbonicAnhydrase: a novel soluble biotherapeutic with no cardiac toxicity for hemorrhagic shock and other uses.

多血红蛋白-过氧化氢酶-超氧化物歧化酶-碳酸酐酶：一种新型可溶性生物治疗剂，无心脏毒性，适用于失血性休克和其他用途。

• 批准号: 297777
• 负责人: Chang Thomas Ming Swi
• 金额: --
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2013
• 资助国家: 加拿大
• 起止时间: 2013-09-01 至 2016-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=297777&lang=en
• 关键词: Anitoxidant Enzymes Catalase Superoxide Dismutase; Carbonic Anhydrase; Hemorrhagic Shock; No Toxic Effect On The Heart; Novel Soluble Biotherapeutic With No Cardiac Toxicity; Tissue Carbon Dioxide; Use Of Red Blood Cell Components

EXTENSIVE BLOOD LOSS from car, plane, bus and train accidents; earthquake; war, terrorism need quick blood replacement. But patients have to be first transported to the hospital for blood group test. Delays in bad weather, traffic jams, earthquake, war or

汽车、飞机、公共汽车和火车事故导致大量失血；地震;战争、恐怖主义需要快速补充血液。但必须先将患者送往医院进行血型检测。因恶劣天气、交通拥堵、地震、战争或